dihydrotetrabenazine has been researched along with Parkinson Disease in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.27) | 18.7374 |
1990's | 5 (11.36) | 18.2507 |
2000's | 15 (34.09) | 29.6817 |
2010's | 22 (50.00) | 24.3611 |
2020's | 1 (2.27) | 2.80 |
Authors | Studies |
---|---|
Bohnen, NI; D'Cruz, N; Kanel, P; Müller, MLTM; Sanchez-Catasus, CA; Yeh, FC | 1 |
Bohnen, JLB; Bohnen, NI; Haugen, J; Müller, MLTM | 1 |
Gjedde, A; Jakobsen, S; Landau, AM; Phan, JA; Romero-Ramos, M; Stokholm, K; Vang, K; Zareba-Paslawska, J | 1 |
Barrett, MJ; Bassett, AS; Berman, BD; Booij, J; Boot, E; Borg, M; Bourdain, F; Butcher, NJ; Charles, P; Clerinx, K; Colin, O; Danaila, T; Drapier, S; Dufournet, B; Fiksinski, AM; Gasser, T; Jacquette, A; Kaneko, S; Lang, AE; Marras, C; Masellis, M; Mills, K; Mok, KY; Mutez, E; Nguyen, K; Perandones, C; Plate, A; Prontera, P; Swillen, A; Udow, S; Vergaelen, E; Vogels, A; Williams, NM; Wood, NW | 1 |
Hsiao, IT; Jung Lung, H; Lin, KJ; Wen, MC; Weng, YH | 1 |
Cervantes-Arriaga, A; Díaz-Meneses, IE; Kerik, NE; Pérez-Lohman, C; Rodríguez-Violante, M | 1 |
Albin, RL; Archer, DB; Bohnen, NI; Burciu, RG; Müller, MLTM; Ofori, E; Roy, A; Vaillancourt, DE; Yang, J | 1 |
Bohnen, NI; Dayalu, P; Kwak, Y; Miller, NS; Müller, ML; Seidler, RD | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Scott, PJ; Studenski, S | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML | 1 |
Hsiao, IT; Hsieh, CJ; Kung, MP; Lin, KJ; Lin, WY; Lu, CS; Weng, YH; Wey, SP; Yen, TC | 1 |
Albin, RL; Bohnen, NI; Constantine, GM; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Scott, PJ; Studenski, S | 1 |
Blesa, J; Cavada, C; Hornykiewicz, O; Obeso, JA; Pifl, C; Rajput, A; Rajput, AH; Reither, H | 1 |
Bohnen, NI; Chou, KL; Koeppe, RA; Lenhart, A | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M; Scott, PJ | 1 |
Collantes, M; Delgado, M; Ecay, M; Gago, B; Iglesias, E; Juri, C; Marín, C; Molinet-Dronda, F; Obeso, JA; Peñuelas, I; Prieto, E; Quiroga-Varela, A | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M; Scott, PJ; Shah, N | 1 |
Albin, RL; Bohnen, NI; Davatzikos, C; Foerster, BR; Frey, KA; Herman, WH; Hsieh, M; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M | 1 |
Frey, KA; Gilman, S; Junck, L; Koeppe, RA; Wernette, K | 1 |
Boileau, I; Guttman, M; Houle, S; Kish, SJ; Rusjan, P; Saint-Cyr, JA; Selby, P; Tong, J; Wilkins, D; Wilson, AA | 1 |
de la Fuente-Fernandez, R; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Troiano, AR | 1 |
Vingerhoets, FJ | 1 |
de la Fuente-Fernández, R; McCormick, S; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ | 1 |
Au, WL; Calne, DB; Cragg, J; de la Fuente-Fernández, R; Kuramoto, L; Lee, CS; Mak, E; McCormick, S; McKenzie, J; Ramachandiran, N; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ | 1 |
Albin, RL; Bogan, CW; Bohnen, NI; Frey, KA; Kilbourn, MR; Koeppe, RA; Müller, ML; Zarzhevsky, N | 1 |
Aasly, JO; Armaly, J; Furay, AR; Hasegawa, K; Leverenz, JB; Shi, M; Sossi, V; Stoessl, AJ; Uitti, RJ; Wang, Y; Wszolek, ZK; Yokoyama, T; Zabetian, CP; Zhang, J | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Gilman, S; Kilbourn, MR; Koeppe, RA; Kotagal, V; Müller, ML | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M | 1 |
Calne, DB; De La Fuente-Fernández, R; Furtado, S; Furukawa, Y; Guttman, M; Lee, CS; Ruth, TJ; Stoessl, AJ | 1 |
Kumar, A; Lee, CS; Mann, S; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ | 1 |
Brooks, DJ; Frey, KA; Marek, KL; Oakes, D; Paty, D; Prentice, R; Shults, CW; Stoessl, AJ | 1 |
Calne, DB; de la Fuente-Fernández, R; Kuramoto, L; Lee, CS; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ | 1 |
Ahlskog, JE; Albin, RL; Brooks, DJ; Carbon, M; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Guttman, M; Gwinn-Hardy, K; Holloway, R; Innis, R; Katz, RG; Kieburtz, K; Kish, SJ; Lange, N; Langston, JW; Marek, K; McFarland, H; Morin, L; Moy, C; Murphy, D; Oertel, WH; Oliver, G; Palesch, Y; Powers, W; Ravina, B; Seibyl, J; Sethi, KD; Sheehy, P; Shults, CW; Stoessl, AJ | 1 |
Adams, JR; Calne, DB; Farrer, M; Gasser, T; Lee, CS; Mak, E; Mckenzie, J; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Strongosky, A; Uitti, RJ; van Netten, H; Wszolek, ZK | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Kilbourn, MR; Koeppe, RA; Minoshima, S; Wernette, KA | 1 |
Martin, WR; Schulzer, M; Stoessl, AJ; Wieler, M | 1 |
Agid, Y; Anglade, P; Brandel, JP; Duyckaerts, C; Hirsch, EC; Javoy-Agid, F; Lehéricy, S; Scherman, D; Villares, J | 1 |
Agid, Y; Javoy-Agid, F; Ruberg, M; Scherman, D | 1 |
Albin, RL; Frey, KA; Gilman, S; Kilbourn, MR; Koeppe, RA; Kuhl, DE; Vander Borght, TM | 1 |
Frey, KA; Kilbourn, MR; Wieland, DM | 1 |
Agid, Y; Duyckaerts, C; Faucheux, B; Hauw, JJ; Herrero, MT; Hirsch, EC; Obeso, JA; Villares, J | 1 |
Calne, DB; de la Fuente-Fernandez, R; Holden, JE; Lee, CS; Pal, PK; Ruth, TJ; Samii, A; Schulzer, M; Sossi, V; Stoessl, AJ; Wudel, J | 1 |
Stoessl, AJ | 1 |
Agid, Y; Blin, J; Desnos, C; Javoy-Agid, F; Pierot, L; Raisman, R; Ruberg, M; Scherman, D | 1 |
3 review(s) available for dihydrotetrabenazine and Parkinson Disease
Article | Year |
---|---|
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Topics: Animals; Basal Ganglia; Biomarkers; Cocaine; Diagnostic Imaging; Dihydroxyphenylalanine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease; Radiopharmaceuticals; Technology Assessment, Biomedical; Tetrabenazine; Tomography, Emission-Computed, Single-Photon; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
The role of radiotracer imaging in Parkinson disease.
Topics: Biomarkers; Biotransformation; Blood-Brain Barrier; Carbon Radioisotopes; Clinical Trials as Topic; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neurons; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Dopamine; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2005 |
Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?
Topics: Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Neural Pathways; Parkinson Disease; Severity of Illness Index; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
41 other study(ies) available for dihydrotetrabenazine and Parkinson Disease
Article | Year |
---|---|
Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of
Topics: Carbon Radioisotopes; Diffusion Tensor Imaging; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine | 2021 |
Mentally stimulating activities associate with better cognitive performance in Parkinson disease.
Topics: Aged; Aged, 80 and over; Carbon Isotopes; Cognition Disorders; Cognitive Behavioral Therapy; Female; Humans; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phosphinic Acids; Piperidines; Positron-Emission Tomography; Regression Analysis; Tetrabenazine | 2017 |
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Carbon Radioisotopes; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals; Rats; Rats, Transgenic; Substantia Nigra; Synapses; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
Topics: Adult; Antiparkinson Agents; Databases, Bibliographic; Deep Brain Stimulation; DiGeorge Syndrome; Female; Humans; International Cooperation; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2018 |
Quantitative study of
Topics: Aged; Brain; Case-Control Studies; Female; Fluorine Radioisotopes; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine | 2018 |
Diagnostic Utility of [11C]DTBZ Positron Emission Tomography In Clinically Uncertain Parkinsonism: Experience of a Single Tertiary Center.
Topics: Adult; Aged; Brain; Carbon Radioisotopes; Female; Humans; Male; Mexico; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2018 |
Multimodal dopaminergic and free-water imaging in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Brain; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tremor; Water | 2019 |
The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbon Isotopes; Cluster Analysis; Corpus Striatum; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Tetrabenazine; Time Factors; Time Perception | 2013 |
Gait speed in Parkinson disease correlates with cholinergic degeneration.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Analysis of Variance; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dioxolanes; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2013 |
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.
Topics: Aged; Body Mass Index; Carbon Radioisotopes; Cardiovascular Diseases; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Imaging, Three-Dimensional; Leukoaraiosis; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Radionuclide Imaging; Reference Values; Rhombencephalon; Risk Factors; Severity of Illness Index; Tetrabenazine | 2014 |
Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tremor | 2014 |
Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Carbon Isotopes; Cross-Sectional Studies; Female; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine; Thiazoles; Vesicular Monoamine Transport Proteins | 2014 |
Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
Topics: Aged; Aged, 80 and over; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Female; Homovanillic Acid; Humans; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Monoamine Transport Proteins | 2014 |
Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Brain; Cognition Disorders; Female; Guanidines; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2014 |
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Topics: Aged; Butyrates; Carbon Isotopes; Cognition Disorders; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Parkinson Disease; Piperidines; Positron-Emission Tomography; Severity of Illness Index; Tetrabenazine | 2014 |
Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
Topics: Adrenergic Agents; Animals; Apomorphine; Brain; Carbon Radioisotopes; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Functional Laterality; Longitudinal Studies; Magnetic Resonance Imaging; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tetrabenazine | 2015 |
Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Analysis of Variance; Aniline Compounds; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Corpus Striatum; Cross-Sectional Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Thiazoles | 2016 |
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
Topics: Aged; Atrophy; Attention; Basal Ganglia; Brain Diseases; Carbon Radioisotopes; Case-Control Studies; Cognition; Cross-Sectional Studies; Diabetes Complications; Dopaminergic Neurons; Executive Function; Female; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine | 2016 |
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine | 2008 |
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
Topics: Adult; Analysis of Variance; Brain Mapping; Central Nervous System Stimulants; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substance Withdrawal Syndrome; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2008 |
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
Topics: Caudate Nucleus; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Female; Humans; Logistic Models; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Tetrabenazine | 2009 |
Dyskinesia in Parkinson disease: back for the future?
Topics: Antiparkinson Agents; Dopamine Agents; Dyskinesias; Humans; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Synapses; Tetrabenazine | 2009 |
Visualizing vesicular dopamine dynamics in Parkinson's disease.
Topics: Antiparkinson Agents; Brain Mapping; Carbon Radioisotopes; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine | 2009 |
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Topics: Adult; Aged; Aging; Carbon Isotopes; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Substantia Nigra; Tetrabenazine; Tritium; Young Adult | 2011 |
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Carbon Isotopes; Corpus Striatum; Denervation; Female; Humans; Leukoaraiosis; Male; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Regression Analysis; Substantia Nigra; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2011 |
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
Topics: alpha-Synuclein; Biomarkers; Carbon Isotopes; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Intracellular Signaling Peptides and Proteins; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Luria-Nebraska Neuropsychological Battery; Male; Methylphenidate; Norway; Oncogene Proteins; Parkinson Disease; Positron-Emission Tomography; Protein Deglycase DJ-1; Protein Serine-Threonine Kinases; Statistics as Topic; Tetrabenazine; United States | 2012 |
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Carbon Radioisotopes; Cognition; Corpus Striatum; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Motor Activity; Neocortex; Parkinson Disease; Positron-Emission Tomography; Propionates; Tetrabenazine; Thalamus | 2012 |
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Carbon Isotopes; Cross-Sectional Studies; Dementia; Female; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Postural Balance; Psychiatric Status Rating Scales; Sensation Disorders; Severity of Illness Index; Tetrabenazine; Thiazoles | 2013 |
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
Topics: Adolescent; Adult; Carbon Radioisotopes; Corpus Striatum; Cytoplasmic Vesicles; Dopamine; Dopamine Agents; Dystonic Disorders; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Middle Aged; Neuropeptides; Parkinson Disease; Raclopride; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dopamine; Fingers; Humans; Image Processing, Computer-Assisted; Levodopa; Middle Aged; Movement; Parkinson Disease; Reaction Time; Synaptic Vesicles; Tetrabenazine; Tomography, Emission-Computed | 2003 |
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Topics: Aged; Brain; Disease Progression; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Regression Analysis; Tetrabenazine | 2004 |
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Topics: Adult; Age Factors; Aged; Brain; Carbon Radioisotopes; Carboxy-Lyases; Case-Control Studies; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Methylphenidate; Middle Aged; Mutation; Parkinson Disease; Phenotype; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Receptors, Dopamine D2; Regression Analysis; Tetrabenazine | 2005 |
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; Algorithms; Biogenic Monoamines; Female; Humans; Male; Middle Aged; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2006 |
Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
Topics: Adult; Aged; Corpus Striatum; Cross-Sectional Studies; Early Diagnosis; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Tetrabenazine | 2008 |
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Binding Sites; Biogenic Monoamines; Corpus Striatum; Female; Humans; Male; Middle Aged; Parkinson Disease; Reference Values; Tetrabenazine; Tritium | 1994 |
Dopamine denervation, age of onset, and Parkinson's disease.
Topics: Age of Onset; Aged; Caudate Nucleus; Denervation; Dopamine; Humans; Middle Aged; Parkinson Disease; Tetrabenazine; Tritium | 1995 |
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
Topics: Adult; Aged; Aging; Animals; Biological Transport; Biomarkers; Blood-Brain Barrier; Cerebral Cortex; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Rats; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1996 |
Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
Topics: Acetylcholine; Alzheimer Disease; Brain; Carbon Radioisotopes; Carrier Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Neuromuscular Depolarizing Agents; Neurons; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Piperidines; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tritium; Vesicular Acetylcholine Transport Proteins; Vesicular Biogenic Amine Transport Proteins; Vesicular Transport Proteins | 1998 |
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Animals; Basal Ganglia; Brain Diseases; Dopamine Agents; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immunohistochemistry; Iodine Radioisotopes; Macaca fascicularis; Male; Parkinson Disease; Supranuclear Palsy, Progressive; Tetrabenazine | 1998 |
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
Topics: Aged; Carbon Radioisotopes; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Down-Regulation; Fluorine Radioisotopes; Homovanillic Acid; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed | 2000 |
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Topics: Adenylyl Cyclases; Adult; Aged; Benzazepines; Caudate Nucleus; Dopamine Antagonists; Humans; Middle Aged; Parkinson Disease; Putamen; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reference Values; Spiperone; Supranuclear Palsy, Progressive; Tetrabenazine | 1988 |